IQVIA LABORATORIES DISCOVERY UK LTD
Get an alert when IQVIA LABORATORIES DISCOVERY UK LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£2.2M
-57.3% vs 2023
Net assets
£62M
-7.2% vs 2023
Employees
706
-8.1% vs 2023
Profit before tax
-£1.2M
-111.3% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2024-12-28
| Metric | Trend | 2023-12-30 | 2024-12-28 | Δ vs prior |
|---|---|---|---|---|
| Turnover | £119,971,000 | £106,253,000 | -11.4% | |
| Operating profit | £12,132,000 | £95,000 | -99.2% | |
| Profit before tax | £10,157,000 | -£1,150,000 | -111.3% | |
| Net profit | £7,831,000 | -£3,886,000 | -149.6% | |
| Cash | £5,210,000 | £2,223,000 | -57.3% | |
| Total assets less current liabilities | £89,058,000 | £79,544,000 | -10.7% | |
| Net assets | £66,517,000 | £61,718,000 | -7.2% | |
| Equity | £66,517,000 | £61,718,000 | -7.2% | |
| Average employees | 768 | 706 | -8.1% | |
| Wages | £34,020,000 | £34,740,000 | +2.1% | |
| Directors' remuneration | £428,000 | £148,000 | -65.4% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-30 | 2024-12-28 |
|---|---|---|---|
| Operating margin | 10.1% | 0.1% | |
| Net margin | 6.5% | -3.7% | |
| Return on capital employed | 13.6% | 0.1% | |
| Gearing (liabilities / total assets) | 45.6% | 44.8% | |
| Current ratio | 1.71x | 1.77x | |
| Interest cover | 5.71x | 0.05x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- IQVIA LABORATORIES DISCOVERY UK LTD 2017-03-01 → present
- BIOFOCUS DPI LTD 2007-06-06 → 2017-03-01
- BIOFOCUS DISCOVERY LIMITED 2002-12-19 → 2007-06-06
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on all of the available evidence, the directors have considered the intent and ability of Charles River Laboratories International, Inc. to provide financial support as required, noting no issues, and consequently have a reasonable expectation that the Company has adequate financial resources to continue in existence for the foreseeable future. In conclusion, they continue to adopt the going concern basis in preparing these financial statements.”
Group structure
- IQVIA LABORATORIES DISCOVERY UK LTD · parent
- KWS Biotest Limited 100%
- Cobra Biologics Holdings Limited 100%
- Fios Genomics Limited 9.89%
Significant events
- “There are no significant events to note.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 21 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| VANCE, Scott David | Secretary | 2024-10-02 | — | — |
| DOLPH, Kerstin Susanne | Director | 2022-10-14 | Aug 1980 | American,German |
| GIRSHICK, Birgit | Director | 2016-09-28 | Jan 1970 | American,German |
| YILMAZ, Peter | Director | 2024-04-02 | Jul 1971 | Dutch |
Show 21 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FRANCE, Stephen John Richard | Secretary | 2002-12-19 | 2005-10-13 |
| PRICE, Sarah Margaret | Secretary | 2014-05-28 | 2024-06-30 |
| PRICE, Sarah Margaret | Secretary | 2014-03-07 | 2014-04-01 |
| VAN DEN EYNDE, Johan Gustaaf Cyriel | Secretary | 2005-10-27 | 2014-01-31 |
| ACKERMAN, Thomas Francis | Director | 2014-04-01 | 2015-08-31 |
| BARNES, Christopher Simon | Director | 2024-10-02 | 2025-12-18 |
| FOSTER, James C | Director | 2014-04-01 | 2015-08-31 |
| FRANCE, Stephen John Richard | Director | 2002-12-19 | 2005-10-13 |
| GREETHAM, Brent Raymond | Director | 2022-06-10 | 2024-04-02 |
| HICKEY, Emily, Dr | Director | 2015-09-01 | 2016-09-23 |
| HILYARD, Katherine Louise, Dr | Director | 2015-09-01 | 2017-11-01 |
| JOHST, David P | Director | 2014-04-01 | 2020-05-20 |
| MACRITCHIE, Jacqueline Anne, Dr | Director | 2017-11-01 | 2024-03-22 |
| MCMILLAN, Henry Geoffrey | Director | 2002-12-19 | 2005-10-13 |
| NEWTON, Christopher Gregory, Dr | Director | 2005-10-27 | 2013-11-22 |
| PRICE, Sarah Margaret | Director | 2020-05-20 | 2024-06-30 |
| SMITH, David Ross | Director | 2014-11-17 | 2022-06-06 |
| SMITH, David Ross | Director | 2014-03-07 | 2014-04-01 |
| STONE, David, Dr | Director | 2002-12-19 | 2003-08-31 |
| SYNNOTT, Aidan John | Director | 2024-03-22 | 2025-01-13 |
| VAN DE STOLPE, Onno, Dr | Director | 2005-10-27 | 2014-04-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Biofocus Dpi Holdings Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 120 total filings
Material constitutional events — rename, articles re-file, resolution
- 2022-09-08 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-12-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-12-23 | TM01 | officers | Termination director company with name termination date | |
| 2025-09-04 | AA | accounts | Accounts with accounts type full | |
| 2025-02-06 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-04 | AP01 | officers | Appoint person director company with name date | |
| 2024-10-04 | AP03 | officers | Appoint person secretary company with name date | |
| 2024-09-06 | AA | accounts | Accounts with accounts type full | |
| 2024-07-24 | TM01 | officers | Termination director company with name termination date | |
| 2024-07-24 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-06-10 | AP01 | officers | Appoint person director company with name date | |
| 2024-06-10 | TM01 | officers | Termination director company with name termination date | |
| 2024-06-10 | AP01 | officers | Appoint person director company with name date | |
| 2024-06-10 | TM01 | officers | Termination director company with name termination date | |
| 2023-12-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-04 | AA | accounts | Accounts with accounts type full | |
| 2022-12-29 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-10-17 | AP01 | officers | Appoint person director company with name date | |
| 2022-09-08 | SH01 | capital | Capital allotment shares | |
| 2022-09-08 | RESOLUTIONS | resolution | Resolution |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.